| SpectraBase Spectrum ID |
DlCqAm4F7NA |
| Name |
N-(2-Fluorobenzyl)MDA |
| Classification |
Amphetamine designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
287.132156985 u |
| Formula |
C17H18FNO2 |
| InChI |
InChI=1S/C17H18FNO2/c1-12(19-10-14-4-2-3-5-15(14)18)8-13-6-7-16-17(9-13)21-11-20-16/h2-7,9,12,19H,8,10-11H2,1H3 |
| InChIKey |
WBXFSZQVJWAUBD-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
287.334 g/mol |
| Nominal Mass |
287 u |
| Quality |
951 |
| Retention Index |
2208 |
| SMILES |
C=12C(=CC(CC(NCC=3C(=CC=CC3)F)C)=CC1)OCO2 |
| SPLASH |
splash10-0pb9-2900000000-2f115eb77b7b743b2c17 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
MDA,N-(2-Fluorobenzyl)-
1-(1,3-benzodioxol-5-yl)-N-(2-fluorobenzyl)propan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_013435 |
